What patellofemoral OA actually is

Not all knee osteoarthritis (OA) is the same, and the distinction matters more than most patients realise. The knee has three compartments: the inner (medial) and outer (lateral) surfaces, where the thigh and shin bones meet, and the kneecap joint—the patellofemoral joint (PFJ)—where the patella glides along a groove at the front of the femur called the trochlea. Patellofemoral OA (PFOA) affects this front compartment specifically, and it behaves quite differently from OA of the inner or outer knee.

The cartilage that wears in PFOA sits on two opposing surfaces: the underside of the kneecap and the trochlear groove of the femur. Every time the knee bends, these surfaces compress against each other—and the deeper the bend, the greater the force. That single functional fact explains a great deal about which activities provoke symptoms.

PFOA can develop in isolation or alongside medial- or lateral-compartment disease; when it occurs alone, it carries a distinct symptom pattern and responds to a different management pathway. Women are more commonly affected, as are people with a history of patellar instability, malalignment, or sustained high-flexion loading—factors that concentrate stress on those cartilage surfaces long before wear becomes visible on imaging.

Why stairs and slopes cause disproportionate pain

The physics behind this symptom pattern are relatively straightforward once the numbers are put in context. Walking on flat ground keeps the knee fairly extended—flexion at mid-stance is typically only around 10–15°. Stairs demand roughly 60–70° of bend, and that difference carries a steep mechanical penalty: the quadriceps must generate substantially greater force to control and propel the body, and the patellofemoral joint reaction force—which is proportional to both quadriceps force and the mechanical leverage of the extensor mechanism—rises sharply in response. Estimates place the compressive load at the kneecap joint at around 0.5–1 times body weight during ordinary walking; on stairs, that figure climbs to approximately 3–4 times body weight.

Think of it like pressing on a cracked tile. The force alone does not cause the damage—it is the way pressure concentrates in a smaller, already-compromised area that matters. In PFOA, cartilage is thinner and less able to spread load; higher-flexion activities drive that load into the damaged zone.

Slope descent is often the sharpest trigger of all. Walking downhill keeps the knee in a flexed position for longer through each stride than going up, meaning the damaged patellar surface stays pressed against the trochlea for a prolonged portion of every step. Climbing stairs recruits the quadriceps concentrically, which is demanding; descending requires them to work eccentrically as a brake—a different and often more painful muscular mode when the joint beneath is compromised.

Research adds a direct clinical dimension to this picture. In an analysis of 581 people drawn from the Osteoarthritis Initiative cohort, climbing 5–6 flights of stairs per week was associated with a threefold increase in the odds of worsening patellofemoral cartilage scores compared with low-volume stair use. The trochlear surface—the femoral side of the joint—was the most vulnerable subregion (adjusted OR 4.50). People who climbed more than six flights weekly showed less progression, a finding that may reflect survivor or conditioning effects rather than a straightforward benefit of high volume, and should not be read as a licence to load aggressively.

Structural factors that amplify stair pain in some people

Two people can have virtually identical cartilage loss on MRI and yet experience very different levels of stair pain. Joint geometry goes a long way towards explaining that gap.

The trochlear groove is the femoral channel along which the kneecap glides. In some people this groove is shallower than normal—a variation called trochlear dysplasia—and cadaveric modelling shows that this morphology is associated with the highest lateral compressive loads during knee flexion, with the mediolateral component of patellofemoral joint reaction force rising progressively as the knee bends deeper. A shallower groove means the kneecap tracks less securely; during stair climbing, pressure concentrates on the lateral facet rather than spreading evenly across the cartilage surface.

Patellar malalignment works by the same principle. When tracking is off-centre, the contact patch between kneecap and trochlea shrinks, forcing the same mechanical load onto a smaller—and often already-degenerated—area. Research additionally links a relatively thicker dorsal articular bump on the patella and reduced overall joint congruity to greater cartilage loss and symptom severity in PFOA.

The practical upshot is that stair pain in PFOA reflects not just how much cartilage remains, but where the load lands—and how well the joint's geometry distributes it. It also helps explain why managing inflammation alone is often insufficient: the mechanical environment in which damaged cartilage operates plays an equal part in determining how much stairs hurt.

How PFOA is recognised and assessed

Recognising PFOA often begins with the patient's own history before a specialist enters the picture. The characteristic pattern is anterior knee pain—felt around or behind the kneecap—that flares predictably on the activities already described: stairs, slopes, squatting, and crouching. A subtler but telling trigger is prolonged sitting with the knee bent at roughly 90°; many patients notice that standing up after a long journey or a cinema visit produces a sharp, nagging ache. Clinicians sometimes call this the 'theatre sign', and for many patients it is the detail that finally makes the symptom pattern click into place.

On examination, tenderness when the kneecap is pressed firmly against the trochlear groove, and soreness along the patellar facets when the joint is palpated, are common findings. A clinician will also assess how the kneecap tracks during movement, observe gait, and evaluate quadriceps and hip muscle balance—factors that influence how load is distributed through the joint at every step.

MRI is generally the preferred imaging modality when PFOA is suspected, providing detail on cartilage thickness, trochlear shape, and any subchondral bone changes. Plain X-ray may show joint space narrowing in more established disease but misses early cartilage loss entirely.

Crucially, imaging findings and symptoms do not always match. Mild or moderate patellofemoral changes on MRI are relatively common in people with little functional limitation, while others with moderate imaging findings report significant pain. The scan is one input the specialist weighs alongside the clinical history and examination—not a verdict on its own.

Conservative care as the right starting point

Structured physiotherapy is the appropriate starting point for most patients with PFOA, and the evidence gives it more than a token role.

The two most clinically important muscle groups are the vastus medialis oblique (VMO)—the teardrop-shaped portion of the quadriceps that pulls the kneecap medially during straightening—and the hip abductors. Strengthening both improves patellar tracking and distributes load more evenly across the trochlear surface, which is precisely where middle-volume stair climbing concentrates cartilage stress. There is therefore a direct biological rationale for reducing daily stair volume: the dose-response data linking 5–6 flights per week to a three-fold increase in cartilage progression risk suggest that shifting to a lower band may meaningfully slow that process, not merely spare short-term discomfort.

Patellar taping and prefabricated foot orthotics can also reduce lateral PFJ loading in patients whose symptoms appear driven by malalignment. Both are low-risk, low-cost adjuncts that a physiotherapist can trial alongside strengthening work.

Weight management deserves particular emphasis in this condition: because patellofemoral forces on stairs are a multiple of body weight, even a modest reduction—5–10 kg—translates into a meaningful decrease in peak joint load at every step.

A supervised programme of 8–12 weeks is a reasonable timeframe before considering further escalation. Symptoms that plateau or worsen within that window, or that are severe enough to limit daily function from the outset, warrant specialist assessment to determine whether injection therapy is appropriate.

Injection options when conservative care is not enough

For patients whose symptoms have not resolved after a supervised course of physiotherapy, intra-articular injection offers a meaningful next step—though the options differ considerably in how quickly they act, how long the benefit lasts, and how strong the evidence base is for this specific compartment.

Corticosteroid (typically triamcinolone 40 mg) remains the fastest-acting choice. In a 2025 double-blind randomised controlled trial of 60 patients with isolated PFOA, a single corticosteroid injection produced significantly greater pain relief than hyaluronic acid at 48 hours, 72 hours, and one week—differences of roughly 8–10 points on a 100-point pain scale. For patients in significant acute pain, this speed matters. The important caveat is that the advantage did not persist: by six months, the two groups were statistically equivalent on both pain and functional (Kujala) scores. Repeated corticosteroid exposure also carries recognised tissue-related concerns, making it a less attractive option for younger patients or those likely to need multiple injection cycles.

Hyaluronic acid (viscosupplementation) is a credible alternative when there is a preference to avoid steroid. The same trial confirms equivalent benefit at six months, and the broader viscosupplementation literature—including Cochrane-level review—supports its use in knee OA. It is not faster to act than corticosteroid, but for patients thinking about medium-term symptom control rather than rapid relief, it is a reasonable first-choice or follow-on option.

Polyacrylamide hydrogel (Arthrosamid®) is an emerging single-injection option with a different mechanism: rather than lubricating the joint temporarily, the gel integrates into the synovial tissue and may persist far longer. A 2022 case series reported reduction in patellofemoral bone marrow lesions following a single injection in advanced PFOA—a finding that suggests potential subchondral modification beyond simple lubrication. Open-label follow-up data at 12 months support sustained effectiveness. These are promising signals, but the bone marrow finding comes from a small case series and has not yet been replicated in a controlled trial; it should be read as hypothesis-generating rather than definitive.

PRP is used within the wider orthobiologics pathway for knee conditions but currently lacks PFOA-specific randomised trial data and cannot yet be positioned as a standard-of-care option for this compartment.

No large head-to-head trial has yet compared all three modalities directly in isolated PFOA, and the optimal sequencing strategy—whether to start with corticosteroid, move to HA, and consider hydrogel if neither proves durable—is a matter of clinical judgement rather than established protocol. For patients whose symptoms remain uncontrolled despite injection therapy, patellofemoral arthroplasty is a well-defined surgical pathway, with published series reporting a revision rate of approximately 3.9% at medium-term follow-up. Robotic-assisted technique is associated with improved patellar tilt correction in more recent comparative data.

Which option is most appropriate depends on symptom severity, how much urgency there is for relief, prior treatment history, and individual patient factors—the kind of assessment a specialist is best placed to carry out.

1. [1] The relationships between patellofemoral bone remodeling, cartilage composition, and vertical loading rate: PET/MRI in isolated patellofemoral osteoarthritis. (2024). https://doi.org/10.1016/j.joca.2024.09.001 https://doi.org/10.1016/j.joca.2024.09.001
2. [2] Quadriceps force and medio-laterally directed joint force during knee flexion in a personalized patellofemoral joint model. (2025). https://doi.org/10.1186/s12891-025-09397-y https://doi.org/10.1186/s12891-025-09397-y
3. [3] Biomechanical effects of loading methods on the patellofemoral joint during stair climbing: based on statistical parametric mapping analysis. (2025). https://doi.org/10.3389/fbioe.2025.1617823 https://doi.org/10.3389/fbioe.2025.1617823
4. [4] Efficacy of Single Intra-articular 2% Sodium Hyaluronate versus Corticosteroid Injection in Isolated Patellofemoral Osteoarthritis: A Double-Blind, Randomized Controlled Trial. (2025). https://doi.org/10.1016/j.jisako.2025.101038 https://doi.org/10.1016/j.jisako.2025.101038